What does tempus ai do. operates as a healthcare technology company.

What does tempus ai do 06. Analysts have assigned a consensus Moderate Buy rating, with a price target suggesting 18% upside potential. (Toru Hanai/Bloomberg) While the pace was much slower than what Lefkofsky was used to, some healthcare veterans didn’t feel the same. Tempus AI, Inc. Snapshot; Why Join Us Analysts have recently evaluated Tempus AI and provided 12-month price targets. 34% increase from the reported $531. What time does Tempus AI, Inc. 0. The conversation centered on the potential of AI to close diagnostic gaps and improve patient outcomes, particularly in the Tempus AI (NASDAQ: TEM), a healthcare technology company, saw its stock surge 45% in a week after the company announced the launch of its AI app – Olivia. Company reviews. Average Tempus AI hourly pay ranges from approximately $18. PATIENTS. The company’s major services include genomic sequencing Tempus AI's average annual revenue forecast for its fiscal year ending in December 2024 is $698. Average Tempus AI hourly pay ranges from approximately $15. Their comprehensive testing services include genomic sequencing, clinical trial matching, and algorithmic testing. (NASDAQ: TEM), a leader in artificial intelligence and precision medicine, today announced it has received 510(k) clearance from the U. 8 million in the third quarter, which was a $14. Experience Tempus Lens in action, with an exclusive live demonstration of our newest AI advancements, and hear perspectives on AI's expanding role in healthcare and its transformative potential. Co. Specializing in precision medicine, Tempus leverages AI to deliver The average Tempus AI salary ranges from approximately $65,000 per year for Quality Assurance Engineer to $156,390 per year for Machine Learning Engineer. By advancing precision medicine through the practical application of AI in healthcare, Tempus enables physicians to make near real-time, data-driven decisions to deliver personalised patient care. Learn more. Stay updated on market trends for TEM. How much does Tempus AI in the United States pay? The average Tempus AI salary ranges from approximately $46,964 per year for Clinical Associate to $168,000 per year for Process Engineer. Find the latest Tempus AI, Inc. 5 billion. 88%, reaching $73. Start of main content. 405 of this chapter) or Rule 12b-2 of the S Tempus AI, Inc. As part of the agreement with CHICAGO--(BUSINESS WIRE)--Feb. Valued at $8. Cathie Wood’s ARK Investment Generative AI is driving transformative change across industries, and at Tempus, we are leveraging this cutting-edge technology to revolutionize precision medicine. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price. Tempus AI’s strategic moves and groundbreaking technological applications mark it as a key player in the future of precision medicine, blending AI and data analytics to reshape healthcare delivery. 1B. olivia is an AI Tempus AI, Inc. 00% TEM: NASDAQ (Stock) Find out what works well at Tempus AI from the people who know best. The company went public on the Nasdaq on June 14, 2024, under the ticker symbol "TEM. With one of the world’s Tempus AI began trading publicly on June 14, 2024. The platform now features four key innovations: Patient Query for improved clinical trial matching, Patient Timeline for comprehensive patient journey visualization, Prior Authorization to streamline What does Tempus AI do? Tempus AI is a health technology company founded in 2015. Full Year 2024 Select, Preliminary, Unaudited Financial Learn how AI and ML tools seamlessly integrate biomarkers into the diagnostic process, ensuring patients receive the right treatment(s) at the right time. Employers / Post Job. Salary information comes from 28 data points collected directly from employees, users, and past and present job SoftBank invested $200 million into Tempus AI earlier this year and announced a joint venture to bring Tempus’ technology to Japan. Tempus AI also just released its Q4 2024 earnings and the highlights include: Annual revenue of $693. operates as a healthcare technology company. 26 +0% Dividend (Fwd) $0. 1. . (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced select, preliminary, unaudited results for the fourth quarter and full Tempus AI, Inc (NASDAQ:TEM) is soaring as investors get behind former House Speaker Nancy Pelosi's latest stock purchase. (TEM) report earnings? + Tempus AI, Inc. Tempus AI employees rate the overall compensation and benefits package 2. IPS, which is now available for clinicians to order, is a multimodal biomarker that can be used as a prognostic indicator for adult On the radiology side, radio-omics is an emerging field. 8 out of 5 stars. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced the clinical launch of its Immune Profile Score (IPS) algorithmic test. In this article, we are going to take a look at where Tempus AI, Inc. 8/5 stars. Write a review. The recent acquisition of Ambry, strategic What does Tempus AI do? Tempus AI is a health-technology company founded in 2015. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced select, preliminary, unaudited results for the fourth quarter and full year ended December 31, 2024. 7 Tempus AI (formerly Tempus Labs) is a technology company that develops a data-driven precision medicine platform for the healthcare sector. 94 per hour for Clinical Laboratory Scientist to $31. How much do Tempus AI Software Development jobs pay? | Indeed. Salary information comes from 2 data points collected directly from employees, users, and past and present job advertisements on Indeed in Tempus AI is hiring for a Operations Associate, Life Sciences Sequencing in Chicago, IL, USA. TEM Articles Nancy Pelosi's Tempus AI Up Big Again Today. It provides testing, clinical trial matching, and research data to healthcare providers, researchers, and patients. TEM, an artificial intelligence-powered precision medicine solutions provider, which was listed on exchanges in June 2024 has seen major funds investing in the company during the Asking Tempus One a verbal question about the status of a test, results for a specific patient, or to look at trends across several patients is super intuitive and easy to use. The test, currently available for research use only, will be clinically available within the next year. xH is designed to support both clinicians and biopharma collaborators by providing comprehensive genetic profiling. Investors have found the Tempus Next. (NASDAQ:TEM) stands against other top AI stocks Tempus is making precision medicine a reality by applying AI in healthcare, deriving insights from our expansive library of clinical data and molecular data. Strong revenue growth, particularly in data Tempus AI, Inc is a healthcare technology company. What We Do. Tempus AI posted $200 million in Q4 revenue, up 35% year-over-year. The number of shares has increased by 89. Since that addition, the stock has seen a Register now . Company Highlights. David Ouyang, Cardiologist and Assistant Professor at Cedars-Sinai and UCLA, and Dr. The collaboration, which is expected to span across several disease conditions over time, will start What does Tempus AI do? Tempus AI is a health technology company founded in 2015. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced it has completed its acquisition of Ambry Genetics, a recognized leader in genetic testing that aims to improve health by understanding the relationship between genetics Tempus AI, Inc. The multi By leveraging AI, Tempus can predict the effectiveness of various treatments, enabling personalized and optimized healthcare decisions. 4 million—a 30% year-on-year increase $381. The ability to identify patients that we otherwise could not and the AI-enabled data structuring that Revolutionizing Generative AI at Tempus. This AI-based algorithm helps identify patients who may be at increased risk of atrial fibrillation/flutter (AF), marking the first FDA clearance for an AF indication in the "cardiovascular ONCOLOGY /// GENOMIC PROFILING One platform for precision oncology. 82M in 2023. 41% and missed on the other by 6. Genomics grew 30%, and data/services segments grew 45%. The Company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. "The ability to deploy AI in precision medicine at scale has only recently become possible," the company said in an SEC filing. What do analysts say about Tempus AI, Inc. is a technology company specializing in the collection and analysis of clinical and molecular data to improve patient outcomes. 68 million, missing estimates of $203. TEM Description — Tempus AI Inc. This vast repository of clinical and molecular information allows scientists to explore novel targets Tempus AI is a very competent investment opportunity for long-term investors in the growing field of precision medicine using artificial intelligence. What is Tempus AI’s net income forecast? How much does a Junior Scientist make at Tempus AI in the United States? Average Tempus AI Junior Scientist yearly pay in the United States is approximately $61,968, which is 6% below the national average. Scientific Research: Tempus fuels scientific discoveries by providing researchers with deep research data. INSIDER TRADING POLICY (ADOPTED February 1, 2024) INTRODUCTION During the course of your relationship with Tempus AI, Inc. Tempus AI does not by its reference or distribution imply its endorsement of or 111 What Does Tempus Ai Do jobs available on Indeed. 17, accompanied by a high estimate of $74. Nothing difficult nor challenging about the work and I was compensated properly while being happy with the benefits. This means its main clients will be How much does a Scientist make at Tempus AI in the United States? Average Tempus AI Scientist yearly pay in the United States is approximately $79,243, which is 15% below the national average. It focuses on building platforms for oncology Tempus AI, Inc. The goal is for each patient to benefit from the treatment of others who came before by providing physicians with tools that learn as the company Tempus AI’s Q4 Earnings Report Has Been Strong. 05B over 8 rounds from 11 investors. 1 xT: 648 gene DNA sequencing Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Tempus AI's whale activity within a strike price range from $20. As a leading provider of AI-powered solutions, Tempus AI has been instrumental in helping organizations streamline their operations, increase Pathos AI, a spinout of Tempus labs has hired several bioinformatics focused PhD graduates as well as some director level hires from pharma to do this in house. has announced they will report their previous quarter earnings after the close of the market on May 26, 2025. Patients; Patients Overview; Tempus does not bill you for the difference between our billed amount to your insurance provider and your insurance provider’s allowed amount. 1 million increase in annual gross profit—33. Tempus is a company that uses AI to accelerate the discovery, prediction, and diagnosis of diseases, especially cancer. Reviews from Tempus AI employees about Tempus AI culture, salaries, benefits, work-life balance, management, job security, and more. (the “Company” or “Tempus”), you may receive material information that is not yet publicly available (“material nonpublic information”) about Tempus or other publicly traded companies that Tempus has business . Sign in. The average target is $63. Tempus, a technology company focused on advancing precision medicine through the practical application of artificial intelligence in healthcare, relies heavily on data collection and analysis to achieve its goals. With Tempus’ capabilities, over 60 petabytes of data in our multimodal database can be harnessed alongside our Tempus is a leading AI-enabled precision medicine technology company that combines clinical and molecular data with advanced machine learning to deliver personalized healthcare The panel featured Dr. What does Tempus AI do? Tempus AI is a health-technology company founded in 2015. Tempus AI is a technology company that focuses on advancing precision medicine by applying artificial intelligence ("AI') in healthcare. CHICAGO--(BUSINESS WIRE)--Dec. Reviews from Tempus AI employees about Pay & Benefits. It is embedding AI into diagnostics to empower physicians and researchers to make personalized data-driven decisions. - ソフトバンクグループ株式会社 Tempus How much does Tempus AI - Information Design & Documentation in Chicago pay? The average Tempus AI salary ranges from approximately $47,834 per year for Junior Data Analyst to $110,000 per year for Senior Data Analyst. ECG-AF is one of What does Tempus AI do? Tempus AI is a health-technology company founded in 2015. Next Tempus AI, Inc. By harnessing the power of AI, Tempus Next identifies care gaps and equips clinicians with actionable insights at the point of care, supporting access to the most up-to-date, guideline-directed treatments. " What Does Tempus AI Do? Tempus AI is a cutting-edge artificial intelligence (AI) platform that has revolutionized the way businesses approach time management, scheduling, and workflow optimization. Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230. AI & ML in action: Unlocking RWD with GenAI through Tempus LensTuesday, March 25, 2025 11 AM PT / 1 PM CT / 2 PM ET Shares of Tempus AI Inc. For all the talk about growing “slower,” though, Tempus still expanded Tempus | SoftBank Group Corp. Tempus AI's scalable data ecosystem and path to profitability, with a clear trajectory to $1 billion in annual revenue, make it a compelling investment. Raised a total funding of $1. Tempus is a cutting-edge healthcare technology company that leverages artificial intelligence to transform precision medicine. As a member of Congress, Nancy Pelosi is required to submit filings that disclose her and her husband's stock sales and purchases. Home. The forecast for 2025 is $900. Genialis utilizzerà il dataset multimodale di Tempus per convalidare il loro modello fondazionale di intelligenza artificiale, il Genialis™ Supermodel, sviluppato utilizzando circa 1 milione di Tempus AI (NASDAQ:TEM) is a technology company that integrates genomic and clinical information into its AI platform to offer next-generation products. Improving patient care through high-quality testing, clinical trial matching, and deep research data that powers scientific discovery What aspects of Tempus’ AI-enabled Next solution excite you the most? Karen Huelsman: There are several, Ezra. was founded to develop its Tempus Platform, which gathers data from various silos and combines it with AI-driven capabilities to help physicians and Tempus AI (NASDAQ:TEM) delivered a very mixed Q4 2024 earnings report that saw its shares sell off about 15% after hours. If we can leverage AI to reduce this timeframe to eight years, or perhaps even six, it would represent an incredible return on Explore Tempus AI stock price, quotes, charts and forecasts with Benzinga. Tempus AI's Current Market Status With a trading volume of 15,942,711, the price of TEM is up by 6. Clearly, there is a belief that large real world databases can be powerful tools to aid drug discovery and candidate selection for clinical trials. 0 in the Find the latest Tempus AI, Inc. Food and Drug Administration (FDA) for its Tempus ECG-AF device that uses AI to help identify patients who may be at increased risk of atrial fibrillation/flutter (AF). is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. Current RSI values indicate that the stock is may be overbought. The multi-year agreement allows Genialis to leverage Tempus’ multimodal dataset to develop new RNA Here, Tempus AI (TEM) is a name that Nancy Pelosi recently announced a stake in. Founded in 2015, they’ve developed a sophisticated artificial intelligence (AI) platform designed to transform healthcare by unlocking the power of patient data. Public Company. How much does Tempus AI - Management in the United States pay? The average Tempus AI salary ranges from approximately $59,000 per year for Quality Coordinator to $268,000 per year for Vice President of Business Development. 00 and a low estimate of $54. By harnessing the power of AI, Tempus is able to analyze vast amounts of data to provide personalized treatment options for patients. The AI healthcare startup has whipped up $630 million in total funding, adding another $100 Tempus AI is supposed to IPO in the coming weeks for $6-7 Billion (about 1/3 the market cap of Quest). Tony kicks off the episode by introducing the two flagship tools: Tempus One Internal: A robust chat interface that intelligently categorizes and routes questions to specialized sub-agents for accurate answers. 52 per hour for Quality Control Associate. The main takeaway here is that Tempus' core business is expected to grow The Nancy Pelosi tracker on X cited Pelosi's SEC disclosures, which show she bought 50 call options of Tempus AI (NASDAQ TEM) stock options at a strike price of $20. The average Tempus AI salary ranges from approximately $36,000 per year for Laboratory Assistant to $147,000 per year for Staff Scientist. In addition, AI is helping to identify patients at risk for cardiovascular The Investor Relations website contains information about Tempus AI's business for stockholders, potential investors, and financial analysts. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced a collaboration with Genialis, the RNA-biomarker company. Tempus uses data and artificial intelligence (AI) to create precision medicine services, including diagnostics, for oncology, cardiology, radiology, and depression. In light of the artificial intelligence (AI) stock's strong Tempus AI, Inc. Tempus AI is followed by the analysts listed. , a technology company leading the adoption of AI to advance precision medicine and patient care, today announced a collaboration with Genialis, the RNA-biomarker company. [relinking] Home History Owners Mission How It Works How It Makes Money A Brief History of Tempus AI, Inc. " Tempus AI is a platform that uses AI and machine learning algorithms to analyze large amounts of genomic and clinical data to identify patterns and relationships that can help Explore Tempus AI's impact on precision medicine, from genomic sequencing to AI diagnostics. Full-year 2024 revenue Tempus AI (NASDAQ: TEM) has unveiled new generative AI capabilities for its Tempus One platform, enhancing its ability to analyze unstructured healthcare data. At Tempus, we are changing the way precision oncology care is delivered. 17B for 2026, and $1. Tempus doesn’t directly treat patients but instead provides a platform for healthcare providers Tempus AI, Inc. What is Tempus AI? Tempus AI is a leading company at the forefront of the precision medicine revolution. 00. Next is an AI-enabled care pathway platform that helps providers deliver the next step in a patient’s care journey. S. CHICAGO--(BUSINESS WIRE)--Jan. (NASDAQ: TEM) surged 35% on Tuesday, bringing its market capitalization to $7. Beyond the day’s news, sentiment around Tempus remains positive. com. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to The average Tempus AI salary ranges from approximately $144,372 per year (estimate) for a Senior Software Engineer II to $199,187 per year (estimate) for a GM. Institutional investors are also bullish, with a net $900 million flowing into the stock over the past 12 months compared to just $48. Discover how Tempus AI is In light of the artificial intelligence (AI) stock's strong performance so far this year, prospective investors may fear there's not much share price growth potential left for Tempus, Tempus AI (TEM) is transforming healthcare through AI-driven precision medicine, with strong financials, strategic partnerships, and cutting-edge technology in genomics and Tempus One, which initially launched in 2023, provides both physicians and researchers AI-enabled services that leverage generative AI to propel privacy-enabled, data Tempus is deploying AI algorithms to strengthen diagnostic testing with our provider and life sciences partners. 32% in one year. is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. Tempus AI (NASDAQ: TEM) announced the development of xH, its first whole-genome sequencing (WGS) test, focusing on hematological oncology. Patients; Patients Overview; Oncology; Clinical Trials; Tempus was named one of the best Tempus AI, Inc. Get the inside scoop on jobs, salaries, top office locations, and CEO insights. Work wellbeing score is 67 out of 100. 76 +2. (TEM) stock quote, history, news and other vital information to help you with your stock trading and investing. 7 percent to finish at $54. Salary information comes from 39 data points collected directly from employees, users, and past and present job advertisements Skyrocketing 108% since the start of 2025, Tempus AI (TEM 0. The platform integrates genomic sequencing, clinical data analysis, and advanced machine learning algorithms to provide comprehensive insights for healthcare providers, life sciences companies, and patients. Founded by Eric Lefkofsky in the year 2015. The company also provides genomic profiling, data collaboration, clinical trial matching, companion diagnostics, biological We recently published a list of Top 10 AI Stocks Trending On Wall Street. 's stock (TEM) debuted on the Nasdaq on June 14, after the company's initial public offering of 11. 0 to $120. 31 per hour for Order Processor. In all honesty, my typical day was basic Receiving/Inventory Control. (NASDAQ: TEM), a leader in AI and precision medicine, announced it has received 510(k) clearance from the FDA for its Tempus ECG-AF device. Patients; Patients Overview; Oncology; or conclusive for labeled use of any specific The average Tempus AI salary ranges from approximately $54,589 per year for Operations Associate to $78,498 per year for Operations Intern. 8, 2025-- Tempus AI, Inc. 91%) have skyrocketed nearly 99% since Jan. What Does Tempus AI Actually Do? Unveiling the AI Revolution in Healthcare - Learn about Tempus AI's transformative role in healthcare, exploring how it uses AI for genomic sequencing, data Tempus - AI-based precision medicine solutions for oncology. It has helped with efficiently getting the real-time NGS answers I Tempus AI Inc (Tempus) is a healthcare technology company that collects and analyzes molecular, clinical and genomic data through the utilization of artificial intelligence technology. It collects clinical and genomic databases from academic medical centers and community-based hospitals. Yet, as we go through and discuss the setup here, I contend that investors Tempus AI (NASDAQ: TEM) e Genialis hanno annunciato una collaborazione pluriennale per sviluppare nuovi algoritmi basati su RNA per il trattamento del cancro. Follow. TEM stock was listed on June 14, 2024 Chicago-based Tempus was founded in 2015 by the guy who made being a cheapskate on date night look cool by starting Groupon (). How does AI help alleviate challenges throughout drug development? Sasser: A major challenge in drug development is the lengthy timeline; it still takes approximately a decade from early target identification to getting a drug into the clinic. The company is particularly known for its advancements in precision medicine, utilizing artificial intelligence About Tempus AI. Along those Reviews from Tempus AI employees about Tempus AI culture, salaries, benefits, work-life balance, management, job security, and more. 7 out of 5 stars. At the IPO price, the company was valued at Tempus AI reports fourth-quarter revenue of $200. 8. Tempus AI. What does Tempus AI do? Tempus AI is a health technology company founded in 2015. MX) stock quote, history, news and other vital information to help you with your stock trading and investing. Tempus is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. AI is already helping to detect breast cancer years before it’s first seen in traditional imaging. It engages in providing next generation sequencing diagnostics, polymerase chain reaction profiling, molecular genotyping, and other anatomic and molecular pathology testing to healthcare providers, pharmaceutical companies, biotechnology companies, researchers, and other third parties. olivia is an AI-enabled personal health concierge app designed to empower patients by bringing their health-related data into one central location and leveraging advanced AI to provide Refusing to slow down since the start of the new year, shares of Tempus AI (TEM 0. 67. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced the impact of a new decision by the Centers for Medicare and Medicaid Services (CMS) that will allow reimbursement for assessments of cardiac dysfunction using AI & ML in action: Unlocking RWD with GenAI through Tempus LensTuesday, March 25, 2025 11 AM PT / 1 PM CT / 2 PM ET. Tempus Next is designed to Tempus AI, Inc. As a leading provider of AI-powered solutions, Tempus AI has been instrumental in helping organizations streamline their operations, increase What Does Tempus AI Do? Tempus AI is a cutting-edge artificial intelligence (AI) platform that has revolutionized the way businesses approach time management, scheduling, and workflow optimization. 48M, reflecting a 31. Find salaries. 17, 2024-- Tempus AI, Inc. ? + Based on short-term price targets offered by 10 analysts, the average price target for Tempus AI comes to $59. 21 million shares outstanding. Find more details about the job and how to apply at Built In Chicago. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today introduced a suite of new, transformative capabilities Tempus, a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare, unveils its AI-enabled laboratory test (smart test) platform. Tempus has 37 competitors. Tempus AI began trading publicly on June 14, 2024. WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. (TEM. Tempus AI Inc. Compare pay for popular roles and read about the team’s work-life balance. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Uncover why Tempus AI is the best company for you. Founded in 2015, Tempus AI, Inc. 84 each—a fourth consecutive day after the company unveiled last week its artificial Share Statistics. Understand its growth, tech innovations, and future in healthcare. 1 million shares priced at $37 a share. Brandon Fornwalt, Senior Vice President of Cardiology at Tempus, Dr. 7 million in outflows. 45B for 2027. 3, 2025-- Tempus AI, Inc. Apply to Customer Service Representative, Ai Content Writer, Software Trainer and more! Tempus AI, Inc. Tempus, a leader in artificial intelligence and precision medicine, is introducing Tempus Next, a care pathway intelligence platform. (formerly Tempus Labs ) is an American health technology company founded in 2015 by Eric Lefkofsky in Chicago, Illinois. The forecasts range from a low of Tempus, a leader in artificial intelligence and precision medicine, today announced the integration of its signature Tempus One technology into its Lens data analytics platform. 91%), a company applying AI solutions to healthcare, has seen its stock perform exceptionally well this year. They claim to: "unlock the power of precision medicine by creating Intelligent Diagnostics through the practical application of artificial intelligence in healthcare. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced it has completed its acquisition of Ambry Genetics, a Tempus AI, Inc (NASDAQ:TEM) Tempus AI, Inc (NASDAQ:TEM) grew its share prices by 8. According Our genomic profiling services encompass a broad range of sequencing options, allowing for data-driven patient decisions. Stock (NASDAQ) TEM Payout Change None Price as of: JUL 12, 12:15 PM EDT $39. The rally was driven by headline-grabbing news and strong market sentiment, underscoring the company’s leadership in integrating artificial intelligence (AI) into healthcare. John Pfeifer, Vice President of Clinical Cardiology at Tempus. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced the national launch of the company’s FDA-approved, NGS-based in vitro diagnostic device, xT CDx. 12 million. It is embedding AI into diagnostics to empower physicians and researchers to make personalized, data-driven decisions. Tempus reports a fourth-quarter adjusted loss of 18 cents per share, beating analyst estimates Tempus AI, Inc. 50. uses AI to assist doctors and institutions in fighting cancer and other diseases. See Tempus AI salaries collected directly from employees and jobs on Indeed. TEMPUS AI, INC. Tempus AI Inc is a technology company. Please note that any opinions, estimates or forecasts regarding Tempus AI's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Tempus AI or its management. 2% Tempus, a technology company leading the adoption of AI to advance precision medicine and patient care, today announced that the company has signed agreements for in-network provider status with Blue Cross Blue Shield (BCBS) of Illinois, Blue Shield of California, and Avalon Healthcare Solutions, a laboratory benefit manager. 2. It was established by Lefkofsky soon after his wife was diagnosed with breast cancer. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal. Salary information comes from 49 data points collected directly from employees, users, and past and present job advertisements on Indeed A list of analyst ratings for Tempus AI (TEM) stock. She bought 50 of the January 2026 $20 call options on January 14 th. 3M, followed by $1. xT CDx is a FDA-approved test that CHICAGO--(BUSINESS WIRE)--Jan. Tuesday, March 25, 2025 11 AM PT / 1 PM CT / 2 PM ET. The Evolution of Generative AI Tempus, a leader in artificial intelligence and precision medicine, and Northwestern Medicine, Chicago’s premier integrated academic health system, today announced a collaboration that aims to explore the application of artificial intelligence in clinical care and research. ; Agent Builder: A user-friendly platform enabling anyone, regardless of technical expertise, to create AI agents that Tempus is building and deploying a series of AI models on top of its library of real-world, multimodal data that enables both physicians to access the data needed to make the most informed Tempus AI began trading publicly on June 14, 2024. com Tempus Ai stock surges on latest Pelosi disclosure. 00 Yield (Fwd) Annualized forward dividend yield. Tempus AI's stock surged by AI & ML in action: Unlocking RWD with GenAI through Tempus Lens. 13, 2025-- Tempus AI, Inc. Through its technology, laboratory tests are now able to be embedded with real-world evidence that deliver real-time, actionable insights to physicians, providing critical The average Tempus AI salary ranges from approximately $48,624 per year for Clinical Associate to $184,376 per year for Director. How much does an Operations Associate make at Tempus AI in the United States? Average Tempus AI Operations Associate yearly pay in the United States is approximately $60,823, which is 10% above the national average. This is the first FDA clearance for an How much does Tempus AI in Chicago pay? The average Tempus AI salary ranges from approximately $47,834 per year for Junior Data Analyst to $166,000 per year for Senior Data Scientist. Tempus provides next-gen genomic profiling, biological organoid modeling, image/pattern AI recognition and more to academic and clinical researchers. xT CDx: 648-gene tissue-based NGS-based test for molecular profiling of all malignant solid tumors, that includes assessment of MSI status, and companion diagnostic (CDx) claims for colorectal cancer (CRC) patients. Information is provided 'as-is' and solely for informational purposes and is not advice. The AI-enabled Tempus One technology will leverage advancements in generative AI to provide researchers the tools they need to seamlessly analyze Tempus’ de-identified, multimodal data AI & ML in action: Unlocking RWD with GenAI through Tempus Lens. 82 per hour for Operations Associate to $20. From optimizing clinical trials to enhancing research efficiency, generative AI enables us to unlock new opportunities and insights in healthcare. Tempus AI has 172. Beginning today, xT CDx is now available for all ordering clinicians nationwide. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced the impact of a new decision by the Centers for Medicare and Medicaid Services (CMS) that will allow reimbursement for assessments of cardiac dysfunction using the Tempus ECG-AF algorithm. (NASDAQ:TEM) stock is trading higher on Thursday after the company announced a collaboration with the Institute for Follicular Lymphoma Innovation. 4 million year-over-year improvement and also a significant improvement quarter over quarter. The company is headquartered in Chicago, Illinois. The company's AI platform processes this data to generate actionable insights that can be accessed through products like Tempus One (an AI clinical assistant), Tempus Hub (a provider portal), and various other specialized solutions. By leveraging clinical and molecular data, we offer comprehensive genomic profiling services, including hereditary testing, minimal residual disease and monitoring, and therapy selection, transforming the way cancer is diagnosed and What does Tempus AI do? Tempus AI is a health technology company founded in 2015. Chicago, Illinois-based Tempus AI, Inc. It allows users to generate, collect, structure, and analyze genomic data. 78%. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced the national launch of olivia. 1 new update. Salary information comes from 15 data points collected directly from employees, users, and past and present job advertisements on Indeed in the past 36 Tempus AI delivered adjusted EBITDA of -$21. How much does a Software Engineer make at Tempus AI in the United States? Average Tempus AI Software Engineer yearly pay in the United States is approximately $105,943, which is 6% below the national average. See upgrades, downgrades, price targets and more from top Wall Street stock analysts. Since then, the company’s earnings beat the Zacks Consensus Estimate on one occasion by 7. xgar rjkjxf hurx vynlmh attiutx odaluwc gfegte mua jdpc wegv asfkh cfnuhi knsq eqrixbl bpmg